Nikolaos A Trikalinos

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Cancer research communications

Journal of neuroendocrinology

Clinical cancer research : an official journal of the American Association for Cancer Research

Endocrine oncology (Bristol, England)

Washington University in Saint Louis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis Jul 18 2017

United States

Assistant Professor :: Internal Medicine / Oncology

Publications

Nikolaos A Trikalinos, Hyun Kim, Anitha Vijayan, Maxwell Amurao, Vikas Prasad
Use of approved Lu-177 radiopharmaceuticals in patients with end-stage renal disease: A review of the literature and proposed treatment algorithm. Journal of neuroendocrinology 36 (6) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Nikolaos A Trikalinos, Hyun Kim, Anitha Vijayan, Maxwell Amurao, Vikas Prasad
Use of approved Lu-177 radiopharmaceuticals in patients with end-stage renal disease: A review of the literature and proposed treatment algorithm. Journal of neuroendocrinology (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications (2024)
Nikolaos A Trikalinos, Hyun Kim, Anitha Vijayan, Maxwell Amurao, Vikas Prasad
Use of approved Lu-177 radiopharmaceuticals in patients with end-stage renal disease: A review of the literature and proposed treatment algorithm. Journal of neuroendocrinology 36 (6) (2024)
Patrick M Grierson, Rama Suresh, Benjamin Tan, Katrina S Pedersen, Manik Amin, Haeseong Park, Nikolaos A Trikalinos, Jingxia Liu, Nicholas Boice, Amberly Brown, Sapana Bansod, Andrea Wang-Gillam, Kian-Huat Lim
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Syed Ehsanullah, Nikolaos A Trikalinos
Synchronous AML and pancreatic neuroendocrine neoplasm, both successfully treated with somatostatin analogs and decitabine. Endocrine oncology (Bristol, England) 2 (1) (2022)
Robin Park, Manik Amin, Nikolaos A Trikalinos
Temozolomide duration and secondary hematological neoplasms: A literature review and implications for patients with neuroendocrine neoplasms. Journal of neuroendocrinology 34 (7) (2022)
Andrea Wang-Gillam, Kian-Huat Lim, Robert R McWilliams, Rama Suresh, Albert C Lockhart, Amberly Brown, Marcus A Breden, Jad I Belle, John M Herndon, Savannah J Bogner, Katrina S Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia, Feng Gao, Harry H Yoon, Mojun Zhu, Nikolaos A Trikalinos, Lee Ratner, Olivia Aranha, William G Hawkins, Brett H Herzog, David G DeNardo
Defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment refractory pancreatic cancer: A phase I, dose escalation, and expansion study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Nikolaos A Trikalinos, Chet Hammill, Jingxia Liu, Pooja Navale, Kyle Winter, Deyali Chatterjee, Amir Iravani, Manik Amin, Malak Itani
Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms. Abdominal radiology (New York) 47 (12) (2022)
Nikolaos A Trikalinos, John S A Chrisinger, Brian Andrew Van Tine
Common Pitfalls in Ewing Sarcoma and Desmoplastic Small Round Cell Tumor Diagnosis Seen in a Study of 115 Cases. Medical sciences (Basel, Switzerland) 9 (4) (2021)
Bora Youn, Ira B Wilson, Vincent Mor, Nikolaos A Trikalinos, Issa J Dahabreh
Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies. Health services research 56 (3) (2021)
Nikolaos A Trikalinos, Deyali Chatterjee, Kyle Winter, Matthew Powell, Motoyo Yano
Tumor Evolution in a Patient with Recurrent Endometrial Cancer and Synchronous Neuroendocrine Cancer and Response to Checkpoint Inhibitor Treatment. The oncologist 26 (2) (2020)
Nikolaos A Trikalinos, Benjamin R Tan, Manik Amin, Jingxia Liu, Ramaswamy Govindan, Daniel Morgensztern
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014. BMC endocrine disorders 20 (1) (2020)
Bora Youn, Nikolaos A Trikalinos, Vincent Mor, Ira B Wilson, Issa J Dahabreh
Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer. Cancer 126 (5) (2020)
Nikolaos A Trikalinos, Takashi Nihashi, Evangelos Evangelou, Teruhiko Terasawa
Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance. BMJ open 8 (2) (2018)

Nikolaos A Trikalinos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nikolaos A Trikalinos